Martin Körbling

9.7k total citations · 3 hit papers
107 papers, 6.3k citations indexed

About

Martin Körbling is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Martin Körbling has authored 107 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 39 papers in Oncology and 37 papers in Genetics. Recurrent topics in Martin Körbling's work include Hematopoietic Stem Cell Transplantation (56 papers), Lymphoma Diagnosis and Treatment (28 papers) and Chronic Lymphocytic Leukemia Research (23 papers). Martin Körbling is often cited by papers focused on Hematopoietic Stem Cell Transplantation (56 papers), Lymphoma Diagnosis and Treatment (28 papers) and Chronic Lymphocytic Leukemia Research (23 papers). Martin Körbling collaborates with scholars based in United States, Germany and United Kingdom. Martin Körbling's co-authors include Zeev Estrov, Richard E. Champlin, Paolo Anderlini, Sergio Giralt, Gabriela Rondón, Issa F. Khouri, Maher Albitar, Börje S. Andersson, Donna Przepiorka and Marcos de Lima and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Martin Körbling

105 papers receiving 6.1k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

1997 909 citations Sergio Giralt, Gabriela Rondón et al. Blood profile →
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells

2002 611 citations Martin Körbling, Gabriela Rondón et al. profile →
Adult Stem Cells for Tissue Repair — A New Therapeutic Concept?

2003 572 citations Martin Körbling, Zeev Estrov profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Körbling United States	35	3.7k	1.9k	1.7k	1.6k	1.0k	107	6.3k
Gabriela Rondón United States	41	4.7k 1.3×	1.2k 0.6×	2.3k 1.4×	2.1k 1.3×	850 0.8×	254	7.0k
Richard A. Nash United States	48	4.9k 1.3×	1.1k 0.6×	1.6k 0.9×	2.7k 1.7×	833 0.8×	176	7.8k
Αchilles Anagnostopoulos Greece	51	3.5k 1.0×	2.5k 1.3×	3.2k 1.9×	1.8k 1.2×	2.1k 2.0×	287	8.9k
Uday Popat United States	43	4.0k 1.1×	1.5k 0.8×	1.9k 1.1×	1.3k 0.8×	1.3k 1.3×	396	6.6k
M Körbling United States	35	4.0k 1.1×	1.3k 0.7×	1.8k 1.1×	1.5k 0.9×	599 0.6×	102	5.4k
Judith A. Shizuru United States	46	3.6k 1.0×	1.1k 0.6×	2.1k 1.3×	3.7k 2.4×	1.1k 1.1×	179	8.1k
Rima M. Saliba United States	45	3.8k 1.0×	1.1k 0.6×	1.7k 1.0×	1.6k 1.0×	596 0.6×	212	5.7k
R. Willemze Netherlands	35	1.7k 0.5×	1.6k 0.8×	1.0k 0.6×	856 0.5×	1.0k 1.0×	129	4.3k
Mehmet Uzunel Sweden	34	2.1k 0.6×	3.6k 1.9×	1.1k 0.6×	1.5k 0.9×	1.3k 1.2×	78	6.2k
Yang O. Huh United States	35	2.4k 0.7×	1.6k 0.8×	1.2k 0.7×	1.4k 0.9×	664 0.6×	104	4.7k

Countries citing papers authored by Martin Körbling

Since Specialization

Citations

This map shows the geographic impact of Martin Körbling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Körbling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Körbling more than expected).

Fields of papers citing papers by Martin Körbling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Körbling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Körbling. The network helps show where Martin Körbling may publish in the future.

Co-authorship network of co-authors of Martin Körbling

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Körbling. A scholar is included among the top collaborators of Martin Körbling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Körbling. Martin Körbling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chahoud, Jad, Dawen Sui, William D. Erwin, et al.. (2018). Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. Clinical Cancer Research. 24(10). 2304–2311. 8 indexed citations

Khouri, Issa F., Elias Jabbour, Celina Ledesma, et al.. (2017). Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning for Lymphoid Malignancies: 8-Year Results. Blood. 130. 2036–2036. 1 indexed citations

Khouri, Issa F., Alison Gulbis, Denái R. Milton, et al.. (2017). Safety of Addition of Inotuzumab Ozogamicin (CMC 544) to Bendamustine, Fludarabine, and Rituximab (BFR) Allogeneic Conditioning for Lymphoid Malignancies. Blood. 130. 3240–3240.

Khouri, Maria, Elias Jabbour, Alison Gulbis, et al.. (2017). Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 23(8). 1405–1410. 5 indexed citations

Khouri, Issa F., Wei Wei, Martin Körbling, et al.. (2013). Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning: A Novel Regimen Inducing Immunosuppression Without Myelosuppression. Blood. 122(21). 541–541. 2 indexed citations

Ciurea, Stefan O., Peter F. Thall, Xuemei Wang, et al.. (2011). Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 118(22). 5957–5964. 148 indexed citations

Körbling, Martin & Emil J. Freireich. (2011). Twenty-five years of peripheral blood stem cell transplantation. Blood. 117(24). 6411–6416. 108 indexed citations

Beitinjaneh, Amer, Rima M. Saliba, Grace‐Julia Okoroji, et al.. (2011). Autologous and Allogeneic Stem Cell Transplantation for T-Cell Lymphoma: The M.D. Anderson Cancer Center Experience,. Blood. 118(21). 4118–4118. 1 indexed citations

Hosing, Chitra, Rima M. Saliba, Martin Körbling, et al.. (2009). Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American Journal of Hematology. 84(6). 335–337. 82 indexed citations

10.

Khouri, Issa F., Peter McLaughlin, Rima M. Saliba, et al.. (2008). Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab. Blood. 111(12). 5530–5536. 215 indexed citations

11.

Lev, Eli I., Neal S. Kleiman, Yochai Birnbaum, et al.. (2005). Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction. Journal of Vascular Research. 42(5). 408–414. 35 indexed citations

12.

Pentz, Rebecca D., Ka Wah Chan, J. Neumann, Richard E. Champlin, & Martin Körbling. (2004). Designing an Ethical Policy for Bone Marrow Donation by Minors and Others Lacking Capacity. Cambridge Quarterly of Healthcare Ethics. 13(2). 149–155. 13 indexed citations

13.

Estrov, Zeev, Yang O. Huh, David Harris, et al.. (2002). Ex vivo expansion of apheresis‐derived peripheral blood hematopoietic progenitors. Journal of Clinical Apheresis. 17(1). 7–16. 2 indexed citations

14.

Khouri, Issa F., Mark F. Munsell, Susan O’Brien, et al.. (2000). Comparable survival for nonablative and ablative allogeneic transplantation for chronic lymphocytic leukemia (CLL): The case for early intervention. Blood. 96. 13 indexed citations

15.

Körbling, Martin, Donna Przepiorka, Paolo Anderlini, & Richard E. Champlin. (1997). Allogeneic blood stem cell transplantation. 24(4). 12 indexed citations

16.

Przepiorka, Donna, Peter Van Vlasselaer, April Durett, et al.. (1996). Rapid Debulking and CD34 Enrichment of Filgrastim-Mobilized Peripheral Blood Stem Cells by Semiautomated Density Gradient Centrifugation in a Closed System. Journal of Hematotherapy. 5(5). 497–502. 10 indexed citations

17.

Körbling, Martin & Richard E. Champlin. (1996). Peripheral Blood Progenitor Cell Transplantation: A Replacement for Marrow Auto‐ or Allografts. Stem Cells. 14(2). 185–195. 36 indexed citations

18.

Drach, Johannes, Shourong Zhao, Doris Drach, et al.. (1995). Expression of MDR1 by Normal Bone Marrow Cells and its Implication for Leukemic Hematopoiesis. Leukemia & lymphoma. 16(5-6). 419–424. 18 indexed citations

19.

Andreeff, Michael, Saili Zhao, Doris Drach, et al.. (1993). Expression of multidrug resistance (mdr-1) and p53 genes in hematologic cell systems: Implications for biology and gene therapy. 45(2). 131–138. 4 indexed citations

20.

Gückel, F., Gunnar Brix, Wolfhard Semmler, et al.. (1990). Proton Chemical Shift Imaging of Bone Marrow for Monitoring Therapy in Leukemia. Journal of Computer Assisted Tomography. 14(6). 954–959. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact